Coherus BioSciences Inc (CHRS) — Cash Flow Reinvestment Rate
Coherus BioSciences Inc (CHRS) has a Cash Flow Reinvestment Rate of 0.02x as of December 2024, reinvesting $542.00K (capex $0.00 plus investments $-542.00K) from operating cash flow of $28.61 Million. See Coherus BioSciences Inc (CHRS) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Coherus BioSciences Inc Cash Flow Reinvestment Rate (2013–2020)
Historical reinvestment intensity for Coherus BioSciences Inc across 3 annual periods. For the full cash flow conversion analysis, see Coherus BioSciences Inc operating cash flow efficiency.
Annual Cash Flow Reinvestment Rate for Coherus BioSciences Inc (2013–2020)
Year-by-year capital reinvestment analysis for Coherus BioSciences Inc. See CHRS free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 0.05x | $7.39 Million | $154.15 Million | $7.23 Million | ▼ -89.6% |
| 2019 | 0.46x | $13.06 Million | $28.36 Million | $12.90 Million | ▲ +1804.8% |
| 2013 | 0.02x | $373.00K | $15.42 Million | $373.00K | — |